CJC-1295 Ipamorelin Dosage Guide 2026: Optimal Protocols for Australian Men

Quick Answer: The optimal CJC-1295 Ipamorelin dosage for most Australian men in 2026 is 100-300mcg of CJC-1295 (No DAC) combined with 200-300mcg of Ipamorelin, injected 1-3 times daily on an empty stomach. However, precise dosing depends on whether you're using CJC-1295 with DAC (extended half-life) versus No DAC (short half-life), your specific goals (muscle growth vs. recovery vs. longevity), and your individual tolerance profile.

Last Updated: April 2026 | Australian Telehealth Protocol | Evidence-Based

---

If you're exploring peptide therapy through Australian telehealth services like Varney Health, understanding the nuanced dosing of CJC-1295 and Ipamorelin is critical. Unlike generic "one-size-fits-all" recommendations you'll find on international supplement sites, Australian medical protocols in 2026 emphasise precision dosing, titration schedules, and rigorous blood work monitoring to ensure safety and efficacy.

This comprehensive guide provides the current 2026 Australian medical standards for CJC-1295 Ipamorelin dosing, including the crucial distinction between DAC and No DAC formulations, timing protocols relative to your fasting and sleep cycles, and specific biomarker thresholds for monitoring.

What Are CJC-1295 and Ipamorelin? (Brief Mechanism)

Before diving into dosing, understand the mechanism. CJC-1295 is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH), while Ipamorelin is a Growth Hormone Secretagogue (GHS). When combined, they create a synergistic pulse of endogenous Growth Hormone (GH) and Insulin-like Growth Factor-1 (IGF-1) without the side effects of exogenous HGH.

2026 Australian Context: Under current TGA guidelines, these peptides are prescription-only medications (S4 classification) when administered for therapeutic purposes. Australian telehealth clinics like Varney Health provide legal prescription pathways following comprehensive blood work and medical assessment.

Critical Distinction: CJC-1295 DAC vs No DAC Half-Life

This is the most overlooked factor in dosage calculations. Competitors rarely explain how the Drug Affinity Complex (DAC) alters your entire dosing protocol.

CJC-1295 No DAC (Short Half-Life)

• Half-life: 30-60 minutes
• Dosing frequency: 1-3 times daily
• Peak duration: 2-4 hours post-injection
• 2026 Standard Protocol: 100-300mcg per dose, 2-3x daily
• Best for: Timing GH pulses to fasting windows, pre-workout, or bedtime

CJC-1295 DAC (Extended Half-Life)

• Half-life: 24-48 hours
• Dosing frequency: Once daily or every other day
• Peak duration: Sustained release over 24-48 hours
• 2026 Standard Protocol: 100-300mcg once daily
• Best for: Convenience, baseline GH elevation, men with irregular schedules

2026 Medical Consensus: Australian endocrinologists increasingly prefer No DAC for bodybuilding and performance applications (allowing pulse timing), while DAC is favoured for anti-aging and recovery protocols where convenience matters more than timing precision.

Standard Dosage Protocols by Goal

Protocol 1: Muscle Growth & Body Recomposition

Target: Australian men 30-55 seeking hypertrophy

• CJC-1295 (No DAC): 200-300mcg per injection
• Ipamorelin: 200-300mcg per injection
• Frequency: 2-3x daily (morning fasting, pre-workout, bedtime)
• Duration: 8-12 weeks, then 4-week break
• 2026 Cost: $250-$450 AUD per month (varies by compounding pharmacy)

Protocol 2: Recovery & Injury Healing

Target: Men recovering from injury or surgery

• CJC-1295 (No DAC): 100-200mcg per injection
• Ipamorelin: 200-300mcg per injection
• Frequency: 2x daily (morning fasting, bedtime)
• Duration: 4-8 weeks
• Stack with: BPC-157 or TB-500 (see Stacking section)

Protocol 3: Longevity & Metabolic Health

Target: Men 45+ seeking anti-aging benefits

• CJC-1295 (DAC): 100-300mcg
• Ipamorelin: 200-300mcg
• Frequency: Once daily (evening) or every other day
• Duration: Continuous or 12-week cycles with 2-week breaks

4-Week Titration Schedule for Tolerance Assessment

Never start at full dose. Australian telehealth protocols now mandate gradual titration to assess tolerance and minimise side effects (water retention, numbness, excessive hunger).

Week	CJC-1295 (No DAC)	Ipamorelin	Frequency	Goal
Week 1	100mcg	100mcg	1x daily	Assess tolerance, monitor injection site reactions
Week 2	150mcg	200mcg	2x daily	Build tolerance, monitor IGF-1 baseline
Week 3	200mcg	250mcg	2-3x daily	Therapeutic dose initiation
Week 4+	200-300mcg	300mcg	2-3x daily	Full therapeutic protocol

Red Flags to Stop: If you experience severe water retention, numbness/tingling in extremities, or blood glucose <4.0mmol/L during fasting, reduce dose by 50% immediately.

Timing Protocols: Fasting, Sleep & Exercise Windows

Timing is as critical as dosage. The 2026 Australian Peptide Therapy Guidelines emphasise these windows:

Fasting State Requirement

Inject 30-60 minutes before eating or 2+ hours after eating. Food (especially protein) triggers amino acids that can blunt GH secretion. Insulin sensitivity drops GH response by 30-40%.

Sleep Timing

Inject 30 minutes before bed to align with natural GH pulses during slow-wave sleep. This maximises overnight recovery and IGF-1 production.

Pre-Workout Protocol

Inject 60 minutes before resistance training. This timing coincides with the exercise-induced GH pulse, creating a "stacked" effect. Do not inject immediately post-workout as this increases cortisol interference.

2026 Optimisation Strategy:

For maximum results: Morning (fasting) + Pre-workout (60 min prior) + Bedtime (30 min prior). This creates three distinct GH pulses without receptor downregulation.

Blood Work Monitoring: Biomarkers and Thresholds

Australian telehealth clinics require baseline and follow-up blood work. Here are the critical biomarkers and 2026 reference ranges:

Baseline (Before Starting)

• IGF-1: Establish baseline (typically 100-300ng/mL for men 30-55)
• GH (Basal): <5ng/mL expected
• Fasting Glucose: 4.0-5.5mmol/L
• HbA1c: <5.7%
• Testosterone: Total and Free (to ensure no suppression)
• Prolactin: <20mcg/L (Ipamorelin has minimal effect, but monitor)

Follow-Up Schedule

• Week 4: IGF-1, Fasting Glucose
• Week 8: IGF-1, GH (basal), Glucose, HbA1c, Lipid Panel
• Month 6: Full hormone panel including testosterone, SHBG, prolactin

2026 Safety Thresholds

Stop or Reduce Dose If:

• IGF-1 exceeds 350ng/mL (risk of insulin resistance)
• Fasting glucose >5.6mmol/L consistently
• HbA1c rises >5.7%
• IGF-1 rises >40% from baseline (receptor downregulation risk)

Reconstitution Calculations for Different Vial Sizes

Australian compounding pharmacies supply various vial sizes. Here's how to calculate concentrations:

Standard Vial Sizes (2026)

• 5mg vial: Add 2.5mL bacteriostatic water = 2000mcg/mL
• 10mg vial: Add 5mL bacteriostatic water = 2000mcg/mL
• 2mg vial: Add 1mL bacteriostatic water = 2000mcg/mL

Dose Calculation Example

Goal: 200mcg dose from 2000mcg/mL solution

• 200mcg ÷ 2000mcg/mL = 0.1mL
• On a 1mL insulin syringe: 10 units

Common Error: Using 5mg vials with only 1mL water creates 5000mcg/mL concentration. For 200mcg dose, you'd inject 0.04mL (4 units)—hard to measure accurately. Always use 2.5mL+ dilution for precision.

Injection Site Rotation and Absorption Rates

Subcutaneous sites: Abdomen (avoid 2cm around navel), outer thigh, upper arm, buttock.

2026 Rotation Protocol: Inject at least 2cm from previous site, rotate clockwise around abdomen or alternate limbs daily.

Absorption Rate Variations

• Abdomen: Fastest absorption (15-20 min onset)
• Thigh/Arm: Moderate absorption (20-30 min onset)
• Buttock: Slowest (30-45 min onset)

Tip: Use abdomen for pre-workout (faster onset), thigh for bedtime (slower, sustained release).

Stacking Interactions with BPC-157 and TB-500

Many Australian men stack CJC-1295/Ipamorelin with healing peptides. Here are 2026 interaction protocols:

With BPC-157 (Gut/Injury Healing)

• Timing: Inject BPC-157 morning (fasting), CJC-1295/Ipamorelin evening
• Dose Adjustment: No adjustment needed
• Benefit: Enhanced tissue repair without affecting GH axis

With TB-500 (Systemic Recovery)

• Timing: Separate injections by 2+ hours
• Dose Adjustment: Reduce CJC-1295 by 25% if using high-dose TB-500 (>10mg/week)
• Reason: Both increase vascularity; combined may increase blood pressure

With Semaglutide/Wegovy

Critical 2026 Warning: If using GLP-1 agonists for weight loss, reduce CJC-1295/Ipamorelin dose by 30-50%. Both stimulate appetite pathways; combined may cause excessive hunger and glucose dysregulation.

Missed Dose Management (DAC vs No DAC)

Missed Dose: CJC-1295 No DAC

If missed by <6 hours: Inject immediately, then continue schedule.
If missed by >6 hours: Skip and resume next scheduled time. Do not double dose.

Missed Dose: CJC-1295 DAC

If missed by <12 hours: Inject immediately.
If missed by 12-24 hours: Inject at usual time today (you'll get a "catch-up" pulse).
If missed by >24 hours: Resume normal schedule. Do not double dose.

2026 Australian Protocol:

Australian telehealth clinics recommend setting daily alarms and maintaining a "missed dose log" for follow-up appointments. Patterns of missed doses (>20%) warrant protocol review.

Frequently Asked Questions

Q1: Can I take CJC-1295 Ipamorelin without a prescription in Australia?

Answer: No. As of 2026, CJC-1295 and Ipamorelin are Schedule 4 prescription-only medications under Australian law. Importing without prescription violates TGA regulations. Australian telehealth clinics like Varney Health provide legal prescription pathways following blood work assessment.

Q2: What's the difference between CJC-1295 DAC and No DAC dosing?

Answer: DAC (Drug Affinity Complex) extends half-life to 24-48 hours, requiring once-daily dosing (100-300mcg). No DAC has a 30-60 minute half-life, requiring 2-3 daily injections (100-300mcg each) but allows precise timing to fasting/exercise windows.

Q3: How much does CJC-1295 Ipamorelin cost in Australia (2026)?

Answer: Australian telehealth protocols cost $250-$500 AUD per month depending on dosage, vial size, and whether you're using DAC or No DAC. Compounded formulations from accredited pharmacies typically cost $150-$300 AUD per month for standard doses.

Q4: Do I need blood work before starting?

Answer: Yes. Australian medical standards require baseline IGF-1, fasting glucose, HbA1c, testosterone, and prolactin levels before initiation. Follow-up blood work is required at weeks 4 and 8, then monthly during treatment.

Q5: Can I take this with TRT (Testosterone Replacement Therapy)?

Answer: Yes, but spacing is critical. Inject CJC-1295/Ipamorelin at least 4 hours apart from testosterone injections. Monitor IGF-1 closely—combined therapy may increase IGF-1 more than expected, requiring dose adjustments.

Q6: What if I'm on Semaglutide or Ozempic?

Answer: Reduce CJC-1295/Ipamorelin dose by 30-50% and monitor glucose closely. Both peptides affect appetite and glucose metabolism. Consult your Australian telehealth provider before combining.

Q7: How long until I see results?

Answer: Subjective energy improvements: 2-3 weeks. Objective IGF-1 elevation: 4-6 weeks. Measurable body composition changes: 8-12 weeks. Full anti-aging benefits (skin, sleep quality, recovery): 12-16 weeks.

---

Disclaimer: This information is for educational purposes only and does not constitute medical advice. CJC-1295 and Ipamorelin are prescription-only medications in Australia. Consult with an Australian-licensed healthcare provider through a legitimate telehealth service like Varney Health before starting any peptide protocol. Always follow TGA regulations and obtain proper blood work monitoring.

Varney Health provides comprehensive Australian telehealth services for hormone optimisation, including CJC-1295 Ipamorelin protocols. Book a consultation for personalised dosage assessment based on your 2026 blood work.